GPC1 and bladder transitional cell carcinoma: This was in line with the clinical TCGA data from bladder urothelial carcinoma (BLCA) patients where a CoxPH models and KM survival analysis revealed poor survival associated with high expression of GPC1 (see Figures 2 and 3 TCGA-BLCA).